Home/Ellipses Pharma/David Cook

DC

David Cook

Chief Financial Officer

Ellipses Pharma

Therapeutic Areas

Ellipses Pharma Pipeline

Drug	Indication	Phase
EP0031/A400	RET-altered cancers	NDA Submitted
B7H3 Antibody-Drug Conjugate	Not specified (oncology)	Clinical

Leadership Team at Ellipses Pharma

Professor Sir Christopher Evans OBE

Executive Chairman & Founder

Non-Executive Director

Dr. Fahad Khater

Non-Executive Director

View full Ellipses Pharma profile